Cost–utility analysis and drug pricing of once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes patients treated with basal insulin in China
Insulin icodec appears to be more cost effective than degludec if the annual cost of icodec ranges from $597.66 to $736.34 for patients with type 2 diabetes in China.
Authors
- Chendong Qi
- Shanshan Hu (ORCID: https://orcid.org/0009-0004-5708-9744)
- Shengying Gu
- Guorong Fan (ORCID: https://orcid.org/0000-0001-5141-5896)
- Shuowen Wang (ORCID: https://orcid.org/0000-0002-8514-0824)
- Chenyang Shi (ORCID: https://orcid.org/0000-0002-0626-0781)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai First People's Hospital (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1111/dom.15973
- Citations
- 8
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- National Natural Science Foundation of China
- China International Medical Foundation